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Identity 
Note: the three chromosome anomalies are variants of each other, and they share identical features. 
 
inv(3)(q21q26) G-banding (top) - Courtesy Diane H. Norback, Eric B. Johnson, Sara Morrison-Delap Cytogenetics at the Waisman 
Center (left and middle) and Jean-Luc Lai and Alain Vanderhaegen, bottom: t(3;3)(q21;q26) (bottom) G-banding (left) - Courtesy Diane 
H. Norback, Eric B. Johnson, Sara Morrison-Delap (left and center left), Jean-Luc Lai and Alain Vanderhaegen (middle), and R-banding 
(middle right and right) - Courtesy Christiane Charrin. 
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Clinics and pathology 
Disease 
Acute non lymphocytic leukemia (ANLL), often 
preceeded by myelodysplastic syndrome (MDS); MDS; 
may occur as additional anomaly in chronic 
myelogenous leukemia (CML) with t(9;22), with 
thrombocytosis, often at the time of the blast crisis; has 
also been found in other myeloproliferative disorders. 
Phenotype / cell stem origin 
ANLL of various subtypes (M1, M2, M4, M6, M7); 
MDS: often RAEB; an early stem cell, prior to lineage 
commitment, is implicated. 
Epidemiology 
1M/1F; median age is 50 yrs. 
Clinics 
Blood data: elevated or normal (instead of low) 
platelets count; bone marrow: erythroid and 
megakaryocytic dysplasia, with micromegakaryocytes 
with hypolobulated nuclei. 
Cytology 
CD34+, CD13+, CD33+, DR+, but also, coexpression 
of the T-cell characteristic CD7+, showing the 
multilineage involvement. 
Prognosis 
Median survival (from 66 cases herein reviewed) is 
only 4 mths. 
Cytogenetics 
Additional anomalies 
- Alone or with -7 in 30% of cases each;  
- nv(3) can be an additional anomaly to 
t(9;22)(q34;q11)(20%), but, also, t(9;22) has been 
found additional to inv(3) ! 
- del(5q)(10%). 





RPN1 (ribophorin 1) 
Location: 3q21 




RPN1 enhancer juxtaposed to EVI1. 
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